v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 43,942 $ 46,628
Accounts receivable 479 916
Short-term investments 95,190 157,029
Prepaid expenses and other current assets 4,647 4,131
Total current assets 144,258 208,704
Long-term investments 0 1,472
Property and equipment, net 48,906 56,925
Operating lease right-of-use assets 40,011 41,609
Restricted cash 5,100 10,227
Total assets 238,275 318,937
Current liabilities:    
Accounts payable 2,925 2,656
Accrued expenses 15,148 20,024
CIRM award liability, current portion 9,508 8,448
Deferred revenue 0 381
Operating lease liabilities, current portion 5,110 4,562
Total current liabilities 32,691 36,071
CIRM award liability, net of current portion 2,377 2,112
Operating lease liabilities, net of current portion 69,383 73,287
Stock price appreciation milestones 792 283
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized shares-5,000,000; Class A Convertible Preferred shares issued and outstanding-2,755,086 at September 30, 2026 and December 31, 2025 3 3
Common stock, $0.001 par value; authorized shares-350,000,000; issued and outstanding-121,533,910 at September 30, 2026 and 115,359,735 at December 31, 2025 122 115
Additional paid-in capital 1,759,430 1,741,259
Accumulated other comprehensive income (loss) (155) 116
Accumulated deficit (1,626,368) (1,534,309)
Total stockholders’ equity 133,032 207,184
Total liabilities and stockholders’ equity $ 238,275 $ 318,937